Health policy
Shorenstein APARC616 Serra StreetEncina Hall E301Stanford, CA 94305-6055
(650) 725-2507 (650) 723-6530
0
pham_ngoc_minh.jpg Ph.D.

Pham Ngoc Minh joins the Walter H. Shorenstein Asia-Pacific Research Center (Shorenstein APARC) as the 2014-2015 Developing Asia Health Policy Fellow as a health researcher and administrator.

His main interests are public health, disease prevention and the rural-urban divide in developing countries. At Stanford, Pham will be studying epidemiological trends and policy perspectives of diabetes in Vietnam, particularly those among adults in mountainous areas of that country. Pham has more than six years of experience working as a medical lecturer at the Thai Nguyen University of Medicine and Pharmacy in Vietnam, and spent two and a half years conducting postdoctoral research in Japan. He received a Bachelor of Medicine from the Thai Nguyen University of Medicine and Pharmacy, a BA in English from Hanoi University, an MPH from the University of Melbourne, and a PhD in medical science from Kyushu University.

2014-2015 Developing Asia Health Policy Postdoctoral Fellow
-

Average life expectancy in Mongolia is 65 years, much shorter than that of other East Asian countries such as South Korea (78.5 years) and China (72.5 years). Furthermore, healthy life expectancy in Mongolia is even shorter, rendering the situation even more tragic. The World Health Organization estimates that the healthy life expectancy is 53 years for males and 58 years for females.

This colloquium will provide an overview of health in Mongolia and its healthcare system, with expertise from two speakers. First, Dr. Gendengarjaa Baigalimaa, Developing Asia Health Policy Fellow at Shorenstein APARC, will discuss her comparative study of how knowledge of cervical cancer risk factors has influenced behavior changes in Mongolia before and after the introduction of the National Cervical Cancer Program.

Second, Dr. Dashdorj will present on overview of the healthcare initiatives of the Onom Foundation, designed to mitigate excess and premature mortality of Mongolians via knowledge transfer and entrepreneurship. He will report on a March national health policy meeting in Mongolia’s capital and recent strides in health improvement made with the support of the Onom Foundation.

Gendengarjaa Baigalimaa joins the Walter H. Shorenstein Asia-Pacific Research Center (Shorenstein APARC) during the 2013-2014 academic year as the Developing Asia Health Policy Fellow. She joins APARC from the Mongolian National Cancer Center, where she serves as a Gynecological Oncologist.

During her appointment as Health Policy Fellow, she is completing her comparative study of how knowledge of cervical cancer risk factors has influenced behavior changes in Mongolia before and after the introduction of the National Cervical Cancer Program.

Baigalimaa is the Executive Director of Mongolian Society of Gynecological Oncologists and is also a member of the International Gynecological Cancer Society (IGCS) in Mongolia, Russia, and France.

Baigalimaa holds a MD from Minsk Belarussia Medical University. She also received a Masters in Health Science from Mongolian Medical University. She is fluent in both Russian and English.

Dr. Dashdorj hails from very humble beginnings. He was born and raised in the southwestern outskirts of Mongolia known as Gobi-Altay province, where the Altay Mountains border with the bare rock covered desert basins of the Gobi. Because of the unique upbringing, Dr. Dashdorj has a profound commitment for making a tangible difference in lives of fellow Mongols. At the same time, he strongly believes that entrepreneurship is the best vehicle for making a difference.

He obtained a Ph.D. in physics from Purdue University in 2005 and was a postdoctoral fellow at the US National Institutes of Health. His research using ultrafast optical spectroscopy and time-resolved x-ray imaging techniques is published in 17 original manuscripts in prominent, peer-reviewed scientific journals, such as the Proceedings of the National Academy of Sciences. In 2010, Dr. Dashdorj became a faculty member at the Argonne National Laboratory. Despite his successes in scientific research, he gave up his academic career in 2013 to pursue his entrepreneurial dreams, since he truly believed that he can make a tangible difference via entrepreneurship, experimenting with a model of subsidizing philanthropic actions by a certain percentage of equity and profits of a for-profit company.

Philippines Conference Room

Shorenstein APARC
Encina Hall E332
616 Serra Street
Stanford, CA 94305-6055

(650) 724-5710 (510) 705-2049 (650) 723-6530
0
Developing Asia Health Policy Fellow
IMG_4537.jpg MD

Gendengarjaa Baigalimaa joins the Walter H. Shorenstein Asia-Pacific Research Center (Shorenstein APARC) during the 2013-2014 acedemic year as the Asia Health Policy Program Fellow. She joins APARC from the Mongolian National Cancer Center, where she serves as a Gynecological Oncologist.

During her appointment as Health Policy Fellow, she will conduct a comparative study of how knowledge of cervical cancer risk factors has influenced behavior changes in Mongolia before and after the introduction of the National Cervical Cancer Program.

Baigalimaa is the Executive Director of Mongolian Society of Gynecological Oncologists and is also a member of the International Gynecological Cancer Society (IGCS) in Mongolia, Russia, and France.

Baigalimaa holds a MD from Minsk Belarussia Medical University. She also received a Masters in Health Science from Mongolian Medical University. She is fluent in both Russian and English.

Gendengarjaa Baigalimaa Developing Asia Health Policy Fellow Speaker Stanford University
Naranbaatar Dashdorj Founder and Chairman of Onom Foundation and a 2014 Sloan Fellow at the Stanford Graduate School of Business Speaker
Seminars
-

This study analyzes the effects of Indonesia's conditional cash transfer program on the local health care market in terms of price, utilization, and quality of care. The CCT program is associated with increased delivery fees and increased utilization of prenatal care and trained attendants for delivery assistance. Consequently, program participants experience improvements in prenatal care quality. 

Margaret Triyana is the Asia Health Policy Post-doctoral fellow. Her main interests are inequality and human capital investments, particularly early health investments in developing countries.

Philippines Conference Room
Encina Hall 3rd Floor Central
616 Serra Street,
Stanford University

Shorenstein APARC
Encina Hall C331
616 Serra Street
Stanford, CA 94305-6055

(650) 724-5656 (650) 723-6530
0
2013-2014 Asia Health Policy Postdoctoral Fellow
triyana_photo.jpg PhD

Margaret (Maggie) Triyana’s main research interests are inequality and human capital investments in developing countries. In particular, she is interested in the effects social policy changes on children’s health outcomes. As a Postdoctoral Fellow, she will analyze the effects of rural-urban migration in Indonesia and China, as well as the impact of health insurance expansion in Indonesia and Vietnam.

Triyana received a PhD in Public Policy from the University of Chicago in 2013.

 

Working Papers

“Do Health Care Providers Respond to Demand-Side Incentives? Evidence from Indonesia“

“The Effects of Community and Household Interventions on Birth Outcomes: Evidence from Indonesia”

“The Longer Term Effects of the ‘Midwife in the Village’ Program in Indonesia”

“The Sources of Wage Growth in a Developing Country” (with Ioana Marinescu)

Margaret Triyana Postdoctoral Fellow in Asia Health Policy Speaker Stanford University
Seminars
Paragraphs
Abstract

Background: Body mass index (BMI) and waist circumference (WC) are used in risk assessment for the development of noncommunicable diseases (NCDs) worldwide. Within a Cambodian population, this study aimed to identify an appropriate BMI and WC cutoff to capture those individuals that are overweight and have an elevated risk of vascular disease.

Methodology/Principal Findings: We used nationally representative cross-sectional data from the STEP survey conducted by the Department of Preventive Medicine, Ministry of Health, Cambodia in 2010. In total, 5,015 subjects between age 25 and 64 years were included in the analyses. Chi-square, Fisher’s Exact test and Student t-test, and multiple logistic regression were performed. Of total, 35.6% (n=1,786) were men, and 64.4% (n=3,229) were women. Mean age was 43.0 years (SD = 11.2 years) and 43.6 years (SD = 10.9 years) for men and women, respectively. Significant association of subjects with hypertension and hypercholesterolemia was found in those with BMI $23.0 kg/m2 and with WC .80.0 cm in both sexes. The Area Under the Curve (AUC) from Receiver Operating Characteristic curves was significantly greater in both sexes (all p-values, 0.001) when BMI of 23.0 kg/m2 was used as the cutoff point for overweight compared to that using WHO BMI classification for overweight (BMI $25.0 kg/m2) for detecting the three cardiovascular risk factors. Similarly, AUC was also significantly higher in men (p-value, 0.001) when using WC of 80.0 cm as the cutoff point for central obesity compared to that recommended by WHO (WC $94.0 cm in men).

Conclusion: Lower cutoffs for BMI and WC should be used to identify of risks of hypertension, diabetes, and hypercholesterolemia for Cambodian aged between 25 and 64 years.

All Publications button
1
Publication Type
Journal Articles
Journal Publisher
PLoS ONE
Authors
Siyan Yi
Paragraphs

How do demand- and supply-side incentives interact, when there are potentially large provider income effects? We develop a simple model and empirically test it with data from China’s Essential Medications List (EML) policy, which reduced patient copayments and changed provider incentives by removing a large source of revenue from primary care providers: drug dispensing revenues. Using a panel of patient-level spending and clinical data for Chinese patients with diabetes or hypertension over two and a half years, we find evidence of strategic provider response that dampened the impact of patient copayment reductions. Resource use and patient out-of-pocket spending did not change, when taking account of patient utilization outside primary care.

This paper has been published: Brian Chen, Y. Tony Yang, and Karen Eggleston, 2017.  Patient Copayments, Provider Incentives and Income Effects: Theory and Evidence from the Essential Medications List under China’s 2009 Healthcare Reform,” World Medical & Health Policy 9(1): 24–44."

All Publications button
1
Publication Type
Working Papers
Publication Date
Journal Publisher
Asia Health Policy Program working paper # 37
Authors
Karen Eggleston

Shorenstein APARC
Encina Hall E332
616 Serra Street
Stanford, CA 94305-6055

(650) 724-5710 (510) 705-2049 (650) 723-6530
0
Developing Asia Health Policy Fellow
IMG_4537.jpg MD

Gendengarjaa Baigalimaa joins the Walter H. Shorenstein Asia-Pacific Research Center (Shorenstein APARC) during the 2013-2014 acedemic year as the Asia Health Policy Program Fellow. She joins APARC from the Mongolian National Cancer Center, where she serves as a Gynecological Oncologist.

During her appointment as Health Policy Fellow, she will conduct a comparative study of how knowledge of cervical cancer risk factors has influenced behavior changes in Mongolia before and after the introduction of the National Cervical Cancer Program.

Baigalimaa is the Executive Director of Mongolian Society of Gynecological Oncologists and is also a member of the International Gynecological Cancer Society (IGCS) in Mongolia, Russia, and France.

Baigalimaa holds a MD from Minsk Belarussia Medical University. She also received a Masters in Health Science from Mongolian Medical University. She is fluent in both Russian and English.

Subscribe to Health policy